What does current evidence show?
NICE's current early-value assessment allows specified robot-assisted orthopaedic systems, including MAKO, to be used while further evidence is generated. NICE notes that robotic systems aim to improve precision of implant positioning, while the longer-term clinical advantages remain an evolving area of evidence.
Knee replacement
The UK RACER-Knee randomised trial, published in The Lancet in September 2026, found that MAKO robotic-assisted total knee replacement did not provide a clinically meaningful patient-reported benefit at 12 months compared with conventional instruments. Safety was similar and robotic surgery was more costly.
Hip replacement
Randomised and systematic-review evidence generally supports improved reproducibility of component positioning. However, evidence for clear long-term clinical superiority remains less certain, and results should not be over-interpreted.
What this means for you: robotics can support planning and precision, but cannot guarantee less pain, faster recovery, fewer complications or a longer-lasting implant.
Robotic hip or robotic knee?
The planning questions and evidence differ between hip and knee replacement, so each has its own detailed page.

